Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Natural history of left ventricular ejection fraction in patients with heart failure.

Clarke CL, Grunwald GK, Allen LA, Barón AE, Peterson PN, Brand DW, Magid DJ, Masoudi FA.

Circ Cardiovasc Qual Outcomes. 2013 Nov;6(6):680-6. doi: 10.1161/CIRCOUTCOMES.111.000045. Epub 2013 Oct 15.

PMID:
24129973
[PubMed - in process]
2.

Heart failure with preserved ejection fraction in African Americans: The ARIC (Atherosclerosis Risk In Communities) study.

Gupta DK, Shah AM, Castagno D, Takeuchi M, Loehr LR, Fox ER, Butler KR, Mosley TH, Kitzman DW, Solomon SD.

JACC Heart Fail. 2013 Apr;1(2):156-63.

PMID:
23671819
[PubMed - in process]
Free PMC Article
3.

Clinical characteristics and long-term clinical outcomes of Japanese heart failure patients with preserved versus reduced left ventricular ejection fraction: a prospective cohort of Shinken Database 2004-2011.

Kaneko H, Suzuki S, Yajima J, Oikawa Y, Sagara K, Otsuka T, Matsuno S, Kano H, Uejima T, Koike A, Nagashima K, Kirigaya H, Sawada H, Aizawa T, Yamashita T.

J Cardiol. 2013 Aug;62(2):102-9. doi: 10.1016/j.jjcc.2013.03.013. Epub 2013 Jun 2.

PMID:
23731923
[PubMed - indexed for MEDLINE]
4.

Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions.

Verbrugge FH, Duchenne J, Bertrand PB, Dupont M, Tang WH, Mullens W.

Am J Cardiol. 2013 Dec 15;112(12):1913-20. doi: 10.1016/j.amjcard.2013.08.013.

PMID:
24286620
[PubMed - indexed for MEDLINE]
5.

Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Davis BR, Kostis JB, Simpson LM, Black HR, Cushman WC, Einhorn PT, Farber MA, Ford CE, Levy D, Massie BM, Nawaz S; ALLHAT Collaborative Research Group.

Circulation. 2008 Nov 25;118(22):2259-67. doi: 10.1161/CIRCULATIONAHA.107.762229. Epub 2008 Nov 10.

PMID:
19001024
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.

Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM, Carson PE.

Circ Heart Fail. 2011 May;4(3):324-31. doi: 10.1161/CIRCHEARTFAILURE.110.959890. Epub 2011 Feb 24.

PMID:
21350053
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study.

Takada T, Sakata Y, Miyata S, Takahashi J, Nochioka K, Miura M, Tadaki S, Shimokawa H; CHART-2 Investigators.

Eur J Heart Fail. 2014 Mar;16(3):309-16. doi: 10.1002/ejhf.22. Epub 2013 Dec 31.

PMID:
24464774
[PubMed - in process]
8.

In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.

Senni M, Gavazzi A, Oliva F, Mortara A, Urso R, Pozzoli M, Metra M, Lucci D, Gonzini L, Cirrincione V, Montagna L, Di Lenarda A, Maggioni AP, Tavazzi L; IN HF Outcome Investigators.

Int J Cardiol. 2014 May 1;173(2):163-9. doi: 10.1016/j.ijcard.2014.02.018. Epub 2014 Feb 22.

PMID:
24630337
[PubMed - in process]
9.

Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction.

Maeder MT, Kaye DM.

Int J Cardiol. 2012 Mar 8;155(2):249-56. doi: 10.1016/j.ijcard.2010.10.007. Epub 2010 Oct 28.

PMID:
21035207
[PubMed - indexed for MEDLINE]
10.

Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction.

Ho JE, Lyass A, Lee DS, Vasan RS, Kannel WB, Larson MG, Levy D.

Circ Heart Fail. 2013 Mar;6(2):279-86. doi: 10.1161/CIRCHEARTFAILURE.112.972828. Epub 2012 Dec 27.

PMID:
23271790
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Depressive symptoms are common and associated with adverse clinical outcomes in heart failure with reduced and preserved ejection fraction.

Kato N, Kinugawa K, Shiga T, Hatano M, Takeda N, Imai Y, Watanabe M, Yao A, Hirata Y, Kazuma K, Nagai R.

J Cardiol. 2012 Jul;60(1):23-30. doi: 10.1016/j.jjcc.2012.01.010. Epub 2012 Mar 21.

PMID:
22445598
[PubMed - indexed for MEDLINE]
Free Article
12.

Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults.

Alagiakrishnan K, Banach M, Jones LG, Datta S, Ahmed A, Aronow WS.

Ann Med. 2013 Feb;45(1):37-50. doi: 10.3109/07853890.2012.660493. Epub 2012 Mar 13. Review.

PMID:
22413912
[PubMed - indexed for MEDLINE]
13.

Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.

Brouwers FP, de Boer RA, van der Harst P, Voors AA, Gansevoort RT, Bakker SJ, Hillege HL, van Veldhuisen DJ, van Gilst WH.

Eur Heart J. 2013 May;34(19):1424-31. doi: 10.1093/eurheartj/eht066. Epub 2013 Mar 6.

PMID:
23470495
[PubMed - indexed for MEDLINE]
Free Article
14.

Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.

Schwartzenberg S, Redfield MM, From AM, Sorajja P, Nishimura RA, Borlaug BA.

J Am Coll Cardiol. 2012 Jan 31;59(5):442-51. doi: 10.1016/j.jacc.2011.09.062.

PMID:
22281246
[PubMed - indexed for MEDLINE]
Free Article
15.

Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute.

Lee DS, Gona P, Vasan RS, Larson MG, Benjamin EJ, Wang TJ, Tu JV, Levy D.

Circulation. 2009 Jun 23;119(24):3070-7. doi: 10.1161/CIRCULATIONAHA.108.815944. Epub 2009 Jun 8.

PMID:
19506115
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Outcomes in World Health Organization Group II Pulmonary Hypertension: Mortality and Readmission Trends With Systolic and Preserved Ejection Fraction-Induced Pulmonary Hypertension.

Salamon JN, Kelesidis I, Msaouel P, Mazurek JA, Mannem S, Adzic A, Zolty R.

J Card Fail. 2014 Jul;20(7):467-75. doi: 10.1016/j.cardfail.2014.05.003. Epub 2014 May 23.

PMID:
24858070
[PubMed - in process]
17.

Prognostic significance of applying the European Society of Cardiology consensus algorithm for heart failure with preserved systolic function diagnosis.

Almeida P, Rodrigues J, Lourenço P, Maciel MJ, Bettencourt P.

Clin Cardiol. 2012 Dec;35(12):770-6. doi: 10.1002/clc.22044. Epub 2012 Aug 9.

PMID:
22886726
[PubMed - indexed for MEDLINE]
18.

Clinical characteristics and prognosis of heart failure with normal left ventricular ejection fraction in elderly patients.

Liu DP, Wang F, Zeng XZ, Zhang XC.

Chin Med J (Engl). 2012 Aug;125(16):2853-7.

PMID:
22932079
[PubMed - indexed for MEDLINE]
Free Article
19.

Beta-blockers in older patients with heart failure and preserved ejection fraction: class, dosage, and outcomes.

Patel K, Fonarow GC, Ekundayo OJ, Aban IB, Kilgore ML, Love TE, Kitzman DW, Gheorghiade M, Allman RM, Ahmed A.

Int J Cardiol. 2014 May 15;173(3):393-401. doi: 10.1016/j.ijcard.2014.03.005. Epub 2014 Mar 11.

PMID:
24703206
[PubMed - in process]
20.

Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.

Cohen Solal A, Leurs I, Assyag P, Beauvais F, Clerson P, Contre C, Thebaut JF, Genoun M; French National College of Cardiologists.

Arch Cardiovasc Dis. 2012 Jun-Jul;105(6-7):355-65. doi: 10.1016/j.acvd.2012.04.003. Epub 2012 Jun 28.

PMID:
22800720
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk